Rob Neville

Rob is one of the founders of Savara and has served as CEO and President for 6 years. He has recently joined the board of the Cystic Fibrosis Foundation – Central Texas Chapter, a non-profit foundation focused on the treatment and cure of CF. Prior to Savara, Mr. Neville was founder and CEO of the Austin Technology Incubator-based Evity, Inc., which was acquired by BMC in 2000. Based on his work at Evity, Mr. Neville was honored as a finalist for the Ernst & Young Entrepreneur of the Year award. He later founded the management consulting company Clockwise Consulting. Clockwise partnered with local biotech companies, the Texas Children’s Hospital and the Baylor College of Medicine in Houston to develop an ICU-based monitoring and diagnostic device. Mr. Neville holds a post-graduate Engineering degree from the University of Natal South Africa.


Taneli Jouhikainen, MD, PhD, MBA

Dr. Jouhikainen is one of the founders of Savara and serves as Head of Product Development for Savara. During his career as a veteran medical executive, Dr. Jouhikainen has held executive positions with several companies including Interim CEO and Senior Vice President of Product Development at Akela Pharma Inc., President and CEO at Focus Inhalation, Chairman of the Board at Spectrum Medical Sciences, and Director of Clinical Research at Leiras/Schering AG. Dr. Jouhikainen is a licentiate of Medicine from the University of Helsinki, Doctor of Medical Sciences from the University of Helsinki and holds an MBA from the Helsinki School of Economics and Business Administration.

john lord

John Lord, PhD

Dr. Lord serves as Head of Pharmaceutical Development at Savara and is responsible for all CMC activities. He has over 17 years of inhalation product development experience working on candidates ranging from early formulation to commercial drugs. His experience includes leadership roles at numerous pharmaceutical companies including Rhône-Poulenc Rorer and Nektar Therapeutics, with a focus on pharmaceutical development of inhalation products. He has experience across multiple inhalation formulation and device technologies including dry powder inhalers, pressurized metered dose inhalers and nebulizers. Dr. Lord holds a PhD in Pharmaceutics from the University of Bath where he studied particle interactions in dry powder inhalations.


Chris Marich, MBA

Mr. Marich is one of the founders of Savara and serves as Head of Business Operations. He has significant experience managing the financial and logistical components of large multi-team projects across numerous industries including enterprise software and pharmaceutical product development. Mr. Marich has co-founded numerous companies from their inception to exits and specializes in business strategy, corporate structures, fundraising, operations, project management and finance. He holds a BS in Finance and Computer Science from the University of Florida and an MBA from the University of South Florida.


Rebecca Waterbury

Ms. Waterbury serves as Director of Quality at Savara. Prior to Savara, Ms. Waterbury was responsible for Quality and Regulatory Compliance at Abbott Laboratories and has consulted with major drug, device, and combination product companies across the globe. Ms. Waterbury is responsible for the oversight of Clinical Quality and GMP Manufacturing Operations including batch release, quality investigations, validation, quality training, and management of internal/external inspections. Rebecca Waterbury holds a BE in Chemical Engineering and a Juris Doctorate (JD) of Law.